China Resources Boya Warns of Steep 2025 Profit Decline Amid Market Pressures
China Resources Boya Bio-pharmaceutical Group, a key player in blood products and medical aesthetics, has issued a stark profit warning for 2025, projecting net profit attributable to shareholders at